Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Oman

Indian Firms Eye NPI Stake

September 2006 | FDI Alert

A number of leading Indian pharmaceutical firms are reported to be interested in purchasing a stake in Oman-based National Pharmaceutical Industries (NPI). According to sources close to the deal, the Indian suitors are close to finalising terms for a 30% stake, valued at some INR5.4bn

To read the full article, please take a trial.

Related Insight Articles
US-FTA Aiding Growth

Companies / Oman Oman is regarded as having one of the most efficient healthcare systems in the Middle East & North Africa (MENA) region. This factor, alongside rapid population growth and the rising contribution...
May 2007
MoH Focuses On Private Drug Sector

Companies / Oman Oman's Ministry of Health (MoH) has acknowledged that the public health system cannot meet the population's health needs on its own. As a result, the MoH has implemented a number of strategic plans designed...
November 2006
Bayer Launches Levitra In Oman

Companies / Oman German drug giant Bayer has launched its erectile dysfunction (ED) treatment Levitra in Oman. Recent studies have shown that the drug has a 92% efficacy for men suffering from the condition and has the...
June 2006
Oman's Health System Facing Future Challenges

Companies / Oman Despite being one of the smallest markets in the GCC and having relatively low health spending per capita - an estimated US$84 at retail prices - Oman is widely considered to have one of the strongest...
April 2006
Oman, India Increase Drug Sector Co-operation

Companies / Oman However, the country is committed to providing cost-effective treatments to treat chronic diseases. In view of the growing problem of lifestyle-related illness, Oman's need for affordable drugs is pressing....
February 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2010 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS